7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Eye Neoplasms D005134 2 associated lipids
Lithiasis D020347 2 associated lipids
Dental Pulp Calcification D003784 2 associated lipids
Hypertension, Pregnancy-Induced D046110 2 associated lipids
Pasteurellaceae Infections D016871 2 associated lipids
Bone Cysts, Aneurysmal D017824 2 associated lipids
Bone Diseases, Developmental D001848 2 associated lipids
Actinomycosis D000196 2 associated lipids
Fractures, Stress D015775 2 associated lipids
Osteosclerosis D010026 2 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Chang YC and Zhao JH Effects of platelet-rich fibrin on human periodontal ligament fibroblasts and application for periodontal infrabony defects. 2011 Aust Dent J pmid:22126345
Curl L and Sampson W The presence of TNF-alpha and TNFR1 in aseptic root resorption. A preliminary study. 2011 Aust Orthod J pmid:22372265
Kwan JS et al. Heritability of serum osteoprotegerin. 2011 Ann. Hum. Genet. pmid:21762114
Ibrahim T et al. Role of RANK, RANKL, OPG, and CXCR4 tissue markers in predicting bone metastases in breast cancer patients. 2011 Clin. Breast Cancer pmid:21764390
Yamamoto K et al. Effects of mechanical stress on cytokine production in mandible-derived osteoblasts. 2011 Oral Dis pmid:21771211
Chen WJ et al. Association of plasma osteoprotegerin and adiponectin with arterial function, cardiac function and metabolism in asymptomatic type 2 diabetic men. 2011 Cardiovasc Diabetol pmid:21771299
Pepene CE et al. Elevated serum receptor activator of nuclear factor kappa B ligand and osteoprotegerin levels in late-onset male hypogonadism. 2011 Clin Invest Med pmid:21810381
Sheng L et al. [Inhibitory acting mechanism of psoralen-osthole on bone metastasis of breast cancer--an expatiation viewing from OPG/RANKL/RANK system]. 2011 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:21812275
Loncar G et al. Association of increased parathyroid hormone with neuroendocrine activation and endothelial dysfunction in elderly men with heart failure. 2011 J. Endocrinol. Invest. pmid:20820131
Tripathi A et al. Bisphosphonate therapy for skeletal malignancies and metastases: impact on jaw bones and prosthodontic concerns. 2011 J Prosthodont pmid:21883630
Mohamed GB and Abdel-Latif EA Serum osteoprotegerin (OPG) in children with primary nephrotic syndrome. 2011 Saudi J Kidney Dis Transpl pmid:21912025
Lommi JI et al. High-density lipoproteins (HDL) are present in stenotic aortic valves and may interfere with the mechanisms of valvular calcification. 2011 Atherosclerosis pmid:21917259
Embree M et al. Role of subchondral bone during early-stage experimental TMJ osteoarthritis. 2011 J. Dent. Res. pmid:21917603
Hope S et al. Affective symptoms are associated with markers of inflammation and immune activation in bipolar disorders but not in schizophrenia. 2011 J Psychiatr Res pmid:21889167
Giner M et al. Alendronate and raloxifene affect the osteoprotegerin/RANKL system in human osteoblast primary cultures from patients with osteoporosis and osteoarthritis. 2011 Eur. J. Pharmacol. pmid:21050847
To M et al. Osteoprotegerin in sputum is a potential biomarker in COPD. 2011 Chest pmid:21127170
Witasp A et al. Expression of osteoprotegerin in human fat tissue; implications for chronic kidney disease. 2011 Eur. J. Clin. Invest. pmid:21128937
Khoshniat S et al. Phosphate-dependent stimulation of MGP and OPN expression in osteoblasts via the ERK1/2 pathway is modulated by calcium. 2011 Bone pmid:21147284
Durual S et al. Titanium nitride oxide coating on rough titanium stimulates the proliferation of human primary osteoblasts. 2011 Clin Oral Implants Res pmid:21087318
Lee YS and Choi EM Apocynin stimulates osteoblast differentiation and inhibits bone-resorbing mediators in MC3T3-E1 cells. 2011 Cell. Immunol. pmid:21683946
Hossein-nezhad A et al. The influence of folic acid supplementation on maternal and fetal bone turnover. 2011 J. Bone Miner. Metab. pmid:20602129
Schoppet M et al. Crystallizing nanoparticles derived from vascular smooth muscle cells contain the calcification inhibitor osteoprotegerin. 2011 Biochem. Biophys. Res. Commun. pmid:21371424
Pobeha P et al. Relationship between osteoporosis and adipose tissue leptin and osteoprotegerin in patients with chronic obstructive pulmonary disease. 2011 Bone pmid:21376149
Colombini A et al. Plasma and drainage fluid levels of soluble receptor activator of nuclear factor-kB (sRANK), soluble receptor activator of nuclear factor-kB ligand (sRANKL) and osteoprotegerin (OPG) during proximal humerus fracture healing. 2011 Int Orthop pmid:20623281
Krause U et al. Assays of osteogenic differentiation by cultured human mesenchymal stem cells. 2011 Methods Mol. Biol. pmid:21431522
Clemens TL and Karsenty G The osteoblast: an insulin target cell controlling glucose homeostasis. 2011 J. Bone Miner. Res. pmid:21433069
Galliera E et al. Circulating OPG levels are reduced following infliximab treatment and correlate with CRP levels: is serum OPG a potential marker of IBD disease activity? 2011 Inflamm. Bowel Dis. pmid:21433226
Hou L et al. Effects of osteoprotegerin from transfection of pcDNA3.1(+)/chOPG on bioactivity of chicken osteoclasts. 2011 Acta Vet. Scand. pmid:21435269
Baloul SS et al. Mechanism of action and morphologic changes in the alveolar bone in response to selective alveolar decortication-facilitated tooth movement. 2011 Am J Orthod Dentofacial Orthop pmid:21435543
Wang AY Consequences of chronic inflammation in peritoneal dialysis. 2011 Semin. Nephrol. pmid:21439430
Vishvanath A et al. Infantile haemangioma expresses tumour necrosis factor-related apoptosis-inducing ligand (TRAIL), TRAIL receptors, osteoprotegerin and receptor activator for nuclear factor кB ligand (RANKL). 2011 Histopathology pmid:22034880
Vidal C et al. Functional polymorphisms within the TNFRSF11B (osteoprotegerin) gene increase the risk for low bone mineral density. 2011 J. Mol. Endocrinol. pmid:21994215
Hemingway F et al. In vitro generation of mature human osteoclasts. 2011 Calcif. Tissue Int. pmid:21960377
Mödder UI et al. Regulation of circulating sclerostin levels by sex steroids in women and in men. 2011 J. Bone Miner. Res. pmid:20499362
Kaneuji T et al. Mechanisms involved in regulation of osteoclastic differentiation by mechanical stress-loaded osteoblasts. 2011 Biochem. Biophys. Res. Commun. pmid:21459078
Luvizuto ER et al. Raloxifene therapy inhibits osteoclastogenesis during the alveolar healing process in rats. 2011 Arch. Oral Biol. pmid:21536255
Hsieh TP et al. Icariin inhibits osteoclast differentiation and bone resorption by suppression of MAPKs/NF-κB regulated HIF-1α and PGE(2) synthesis. 2011 Phytomedicine pmid:20554188
Al-Dujaili SA et al. Apoptotic osteocytes regulate osteoclast precursor recruitment and differentiation in vitro. 2011 J. Cell. Biochem. pmid:21538477
Stępień E et al. Increased levels of bone remodeling biomarkers (osteoprotegerin and osteopontin) in hypertensive individuals. 2011 Clin. Biochem. pmid:21539822
Zheng Y et al. Vitamin D deficiency promotes prostate cancer growth in bone. 2011 Prostate pmid:21541977
de Souza JA et al. Expression of suppressor of cytokine signaling 1 and 3 in ligature-induced periodontitis in rats. 2011 Arch. Oral Biol. pmid:21511249
Xu ML et al. [An update for the research progress of osteoprotegerin on coronary artery disease]. 2011 Zhonghua Xin Xue Guan Bing Za Zhi pmid:22321243
Karosi T et al. Osteoprotegerin expression and sensitivity in otosclerosis with different histological activity. 2011 Eur Arch Otorhinolaryngol pmid:20963600
Halade GV et al. Obesity-mediated inflammatory microenvironment stimulates osteoclastogenesis and bone loss in mice. 2011 Exp. Gerontol. pmid:20923699
Mitsuhashi M et al. Effects of HSP70 on the compression force-induced TNF-α and RANKL expression in human periodontal ligament cells. 2011 Inflamm. Res. pmid:20924639
Huang CH et al. Osteoprotegerin genetic polymorphisms and age of symptom onset in ankylosing spondylitis. 2011 Rheumatology (Oxford) pmid:20974615
Pepene CE et al. Circulating osteoprotegerin and soluble receptor activator of nuclear factor κB ligand in polycystic ovary syndrome: relationships to insulin resistance and endothelial dysfunction. 2011 Eur. J. Endocrinol. pmid:20974706
Kassi E et al. Effects of Sideritis euboea (Lamiaceae) aqueous extract on IL-6, OPG and RANKL secretion by osteoblasts. 2011 Nat Prod Commun pmid:22224290
Erkol A et al. Relation of circulating osteoprotegerin levels on admission to microvascular obstruction after primary percutaneous coronary intervention. 2011 Am. J. Cardiol. pmid:21247537
Sobue T et al. Murine TMJ loading causes increased proliferation and chondrocyte maturation. 2011 J. Dent. Res. pmid:21248355
Ribeiro FV et al. Cytokines and bone-related factors in systemically healthy patients with chronic periodontitis and patients with type 2 diabetes and chronic periodontitis. 2011 J. Periodontol. pmid:21284550
Vik A et al. Serum osteoprotegerin is a predictor for incident cardiovascular disease and mortality in a general population: the Tromsø Study. 2011 J. Thromb. Haemost. pmid:21284802
Hasegawa T et al. [Animal models for bone and joint disease. Bone disease of osteoprotegerin deficient mouse]. 2011 Clin Calcium pmid:21289415
Qu Z et al. Effect of enamel matrix derivative on proliferation and differentiation of osteoblast cells grown on the titanium implant surface. 2011 Oral Surg Oral Med Oral Pathol Oral Radiol Endod pmid:21232997
Rauch A et al. An anti-inflammatory selective glucocorticoid receptor modulator preserves osteoblast differentiation. 2011 FASEB J. pmid:21233489
Ueland T et al. Osteoprotegerin predicts progression of chronic heart failure: results from CORONA. 2011 Circ Heart Fail pmid:21216833
Alexander KA et al. Osteal macrophages promote in vivo intramembranous bone healing in a mouse tibial injury model. 2011 J. Bone Miner. Res. pmid:21305607
Jabbar S et al. Osteoprotegerin, RANKL and bone turnover in postmenopausal osteoporosis. 2011 J. Clin. Pathol. pmid:21307155
Maïmoun L et al. In peripubertal girls, artistic gymnastics improves areal bone mineral density and femoral bone geometry without affecting serum OPG/RANKL levels. 2011 Osteoporos Int pmid:21359671
Polzer K et al. Proteasome inhibition aggravates tumor necrosis factor-mediated bone resorption in a mouse model of inflammatory arthritis. 2011 Arthritis Rheum. pmid:21360496
Oshita K et al. Human mesenchymal stem cells inhibit osteoclastogenesis through osteoprotegerin production. 2011 Arthritis Rheum. pmid:21360521
Wang SY et al. Circulating Dickkopf-1 is correlated with bone erosion and inflammation in rheumatoid arthritis. 2011 J. Rheumatol. pmid:21362762
Preshaw PM and Taylor JJ How has research into cytokine interactions and their role in driving immune responses impacted our understanding of periodontitis? 2011 J. Clin. Periodontol. pmid:21323705
Sun CX et al. [Patterns of osteoprotegerin or nuclear factor kappa B ligand gene expression in the treatment of bone defect with bone marrow stem cell transplantation and low-frequency vibration]. 2011 Zhonghua Yi Xue Za Zhi pmid:21600122
Basu R et al. Effects of physiological variations in circulating insulin levels on bone turnover in humans. 2011 J. Clin. Endocrinol. Metab. pmid:21325461
Liu ZF et al. [Effect of ultrasound on osteoprotegerin and receptor activator nuclear factor kappaB ligand expression during root resorption in rats]. 2011 Nan Fang Yi Ke Da Xue Xue Bao pmid:21602131
Kamiya N et al. Significance of serum osteoprotegerin and receptor activator of nuclear factor κB ligand in Japanese prostate cancer patients with bone metastasis. 2011 Int. J. Clin. Oncol. pmid:21327451
Blázquez-Medela AM et al. Osteoprotegerin and diabetes-associated pathologies. 2011 Curr. Mol. Med. pmid:21568931
Feng Z et al. An oligodeoxynucleotide with promising modulation activity for the proliferation and activation of osteoblast. 2011 Int J Mol Sci pmid:21731457
Peng S et al. Osteoprotegerin deficiency attenuates strontium-mediated inhibition of osteoclastogenesis and bone resorption. 2011 J. Bone Miner. Res. pmid:21611968
Mai QG et al. Metformin stimulates osteoprotegerin and reduces RANKL expression in osteoblasts and ovariectomized rats. 2011 J. Cell. Biochem. pmid:21618594
Kornak U Animal models with pathological mineralization phenotypes. 2011 Joint Bone Spine pmid:21550285
Kuczkowski J et al. Expression of the receptor activator for nuclear factor-κB ligand and osteoprotegerin in chronic otitis media. 2010 Nov-Dec Am J Otolaryngol pmid:20015790
Kuczkowski J et al. [Molecular control of bone resorption in chronic otitis media with cholesteatoma]. 2010 Jul-Aug Otolaryngol Pol pmid:20873097
Reyes-García R et al. Effects of alendronate treatment on serum levels of osteoprotegerin and total receptor activator of nuclear factor kappaB in women with postmenopausal osteoporosis. 2010 Jan-Feb Menopause pmid:19574937
Mori K et al. Effects of pravastatin on serum osteoprotegerin levels in patients with hypercholesterolemia and type 2 diabetes. 2010 Feb-Mar Angiology pmid:19147525
Grauslund J et al. Does osteoprotegerin relate to micro- and macrovascular complications in long-term type 1 diabetes? 2010 Scand. J. Clin. Lab. Invest. pmid:20205614
Wang L et al. Effects and mechanism of aromatic aminoketone SY0916 on osteoclastic bone destruction. 2010 Acta Pharmacol. Sin. pmid:20208552
Zagura M et al. Association of osteoprotegerin with aortic stiffness in patients with symptomatic peripheral artery disease and in healthy subjects. 2010 Am. J. Hypertens. pmid:20224558
Camozzi V et al. Persistent increase of osteoprotegerin levels after cortisol normalization in patients with Cushing's syndrome. 2010 Eur. J. Endocrinol. pmid:19793762
Pennisi P et al. The association between carotid or femoral atherosclerosis and low bone mass in postmenopausal women referred for osteoporosis screening. Does osteoprotegerin play a role? 2010 Maturitas pmid:20727694
Nezami N et al. Lovastatin raises serum osteoprotegerin level in people with type 2 diabetic nephropathy. 2010 Clin. Biochem. pmid:20727867
Zhang Y et al. Osteogenic properties of hydrophilic and hydrophobic titanium surfaces evaluated with osteoblast-like cells (MG63) in coculture with human umbilical vein endothelial cells (HUVEC). 2010 Dent Mater pmid:20728208
Pi M et al. Impaired osteoblast function in GPRC6A null mice. 2010 J. Bone Miner. Res. pmid:19874200
Secchiero P et al. Baseline serum concentrations of TRAIL in early rheumatoid arthritis: relationship with response to disease-modifying antirheumatic drugs. 2010 J. Rheumatol. pmid:20472926
Scheres N et al. Gingival and periodontal ligament fibroblasts differ in their inflammatory response to viable Porphyromonas gingivalis. 2010 J. Periodont. Res. pmid:19778323
Chang IC et al. Platelet-rich fibrin modulates the expression of extracellular signal-regulated protein kinase and osteoprotegerin in human osteoblasts. 2010 J Biomed Mater Res A pmid:20623670
Liu JM et al. Analysis of recently identified osteoporosis susceptibility genes in Han Chinese women. 2010 J. Clin. Endocrinol. Metab. pmid:20554715
Aoki S et al. Function of OPG as a traffic regulator for RANKL is crucial for controlled osteoclastogenesis. 2010 J. Bone Miner. Res. pmid:20560139
Byron CR et al. In vitro expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in cultured equine articular cells. 2010 Am. J. Vet. Res. pmid:20513175
Vik A et al. Serum osteoprotegerin, sRANKL and carotid plaque formation and growth in a general population--the Tromsø study. 2010 J. Thromb. Haemost. pmid:20128863
Hughes C et al. Human single-chain variable fragment that specifically targets arthritic cartilage. 2010 Arthritis Rheum. pmid:20131274
Makihira S et al. Immobilized-OPG-Fc on a titanium surface inhibits RANKL-dependent osteoclast differentiation in vitro. 2010 J Mater Sci Mater Med pmid:19834789
Tomlins C and Storey A Cutaneous HPV5 E6 causes increased expression of Osteoprotegerin and Interleukin 6 which contribute to evasion of UV-induced apoptosis. 2010 Carcinogenesis pmid:20884685
Rachner TD et al. Zoledronic acid induces apoptosis and changes the TRAIL/OPG ratio in breast cancer cells. 2010 Cancer Lett. pmid:19577359
Bai Y et al. Formation of bone-like tissue by dental follicle cells co-cultured with dental papilla cells. 2010 Cell Tissue Res. pmid:20886237
Wutzl A et al. Bone morphogenetic proteins 2, 5, and 6 in combination stimulate osteoblasts but not osteoclasts in vitro. 2010 J. Orthop. Res. pmid:20872578
Tan YY et al. Effects of vascular endothelial growth factor (VEGF) on MC3T3-E1. 2010 Orthod Craniofac Res pmid:21040465
Gallo J et al. [Synovial fluid from aseptically failed total hip or knee arthroplasty is not toxic to osteoblasts]. 2010 Acta Chir Orthop Traumatol Cech pmid:21040654
Hesse E et al. Zfp521 controls bone mass by HDAC3-dependent attenuation of Runx2 activity. 2010 J. Cell Biol. pmid:21173110

Table of Content